Gα13 Contributes to LPS-Induced Morphological Alterations and Affects Migration of Microglia

Barbara Bettegazzi1,2, Serena Bellani3, Stefano Cattaneo3,4

  • 1IRCCS San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy. bettegazzi.barbara@hsr.it.

Molecular Neurobiology
|September 16, 2021
PubMed

Insights

Small GTPase Gα13 regulates microglial activation by influencing cytoskeletal changes. Inhibiting Gα13 reduces neuroinflammation, suggesting it as a therapeutic target for neurological disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia, the CNS immune cells, activate to maintain homeostasis but can cause neuroinflammation if dysregulated.
  • Chronic microglia activation is a hallmark of neurological disorders, involving complex pathways like cytoskeletal remodeling.
  • The small GTPase Gα13's role in microglia activation, particularly its interaction with RhoA and Rac1 signaling, is under investigation.

Purpose of the Study:

  • To investigate the role of small GTPase Gα13 in microglia activation and cytoskeletal rearrangements.
  • To elucidate the involvement of Gα13 in the FAK, LIMK/cofilin, and Rac1 signaling pathways during pro-inflammatory stimulation.

Main Methods:

  • Utilized Gα13 knockdown to assess its impact on microglia activation.
  • Examined changes in cell morphology and migration following LPS stimulation.
  • Analyzed the modulation of FAK and Rac1 signaling pathways.

Main Results:

  • Gα13 knockdown significantly inhibited LPS-induced microglial activation, affecting morphology and migration.
  • Gα13 modulates FAK and its downstream effector Rac1 during microglia activation.
  • Evidence suggests Gα13 is involved in cytoskeletal rearrangements mediated by FAK, LIMK/cofilin, and Rac1.

Conclusions:

  • Gα13 is a critical regulator of microglial morphological and functional properties during activation.
  • Gα13 plays a key role in cytoskeletal rearrangements essential for microglia response.
  • Gα13 emerges as a potential therapeutic target for controlling neuroinflammation in neurological disorders.